News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,015 Results
Type
Article (43237)
Company Profile (464)
Press Release (686304)
Multimedia
Podcasts (108)
Webinars (20)
Section
Business (209131)
Career Advice (2032)
Deals (36093)
Drug Delivery (110)
Drug Development (83831)
Employer Resources (174)
FDA (16596)
Job Trends (15167)
News (353713)
Policy (33238)
Tag
Academia (2648)
Accelerated approval (18)
Adcomms (28)
Allergies (121)
Alliances (51109)
ALS (142)
Alzheimer's disease (1616)
Antibody-drug conjugate (ADC) (241)
Approvals (16677)
Artificial intelligence (429)
Autoimmune disease (92)
Automation (30)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (20)
Biosimilars (154)
Biotechnology (331)
Bladder cancer (137)
Brain cancer (48)
Breast cancer (502)
Cancer (3974)
Cardiovascular disease (330)
Career advice (1714)
Career pathing (34)
CAR-T (240)
CDC (44)
Cell therapy (647)
Cervical cancer (31)
Clinical research (70112)
Collaboration (1381)
Company closure (4)
Compensation (944)
Complete response letters (52)
COVID-19 (2740)
CRISPR (82)
C-suite (600)
Cystic fibrosis (138)
Data (4818)
Decentralized trials (2)
Denatured (35)
Depression (105)
Diabetes (428)
Diagnostics (6601)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (199)
Drug pricing (168)
Drug shortages (29)
Duchenne muscular dystrophy (207)
Earnings (90267)
Editorial (50)
Employer branding (21)
Employer resources (152)
Events (119246)
Executive appointments (958)
FDA (19096)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1250)
Gene editing (174)
Generative AI (32)
Gene therapy (528)
GLP-1 (914)
Government (4700)
Grass and pollen (6)
Guidances (369)
Healthcare (19189)
HIV (45)
Huntington's disease (38)
IgA nephropathy (65)
Immunology and inflammation (232)
Immuno-oncology (19)
Indications (59)
Infectious disease (2968)
Inflammatory bowel disease (181)
Inflation Reduction Act (16)
Influenza (95)
Intellectual property (194)
Interviews (315)
IPO (16900)
IRA (51)
Job creations (3710)
Job search strategy (1439)
Kidney cancer (15)
Labor market (73)
Layoffs (567)
Leadership (30)
Legal (8016)
Liver cancer (87)
Longevity (11)
Lung cancer (571)
Lymphoma (281)
Machine learning (31)
Management (59)
Manufacturing (616)
MASH (140)
Medical device (13783)
Medtech (13807)
Mergers & acquisitions (20079)
Metabolic disorders (1085)
Multiple sclerosis (136)
NASH (19)
Neurodegenerative disease (220)
Neuropsychiatric disorders (58)
Neuroscience (2637)
NextGen: Class of 2025 (6758)
Non-profit (4565)
Now hiring (59)
Obesity (516)
Opinion (262)
Ovarian cancer (138)
Pain (159)
Pancreatic cancer (172)
Parkinson's disease (237)
Partnered (29)
Patents (410)
Patient recruitment (329)
Peanut (53)
People (59698)
Pharmaceutical (86)
Pharmacy benefit managers (26)
Phase I (22019)
Phase II (30913)
Phase III (22879)
Pipeline (2796)
Policy (262)
Postmarket research (2602)
Preclinical (9458)
Press Release (67)
Prostate cancer (198)
Psychedelics (50)
Radiopharmaceuticals (275)
Rare diseases (664)
Real estate (6045)
Recruiting (70)
Regulatory (24024)
Reports (51)
Research institute (2449)
Resumes & cover letters (353)
Rett syndrome (15)
RNA editing (15)
RSV (67)
Schizophrenia (134)
Series A (207)
Series B (158)
Service/supplier (11)
Sickle cell disease (84)
Special edition (25)
Spinal muscular atrophy (154)
Sponsored (37)
Startups (3789)
State (2)
Stomach cancer (15)
Supply chain (95)
Tariffs (80)
The Weekly (71)
Vaccines (935)
Venture capital (66)
Weight loss (342)
Women's health (57)
Worklife (18)
Date
Today (280)
Last 7 days (818)
Last 30 days (2891)
Last 365 days (31451)
2025 (26299)
2024 (36300)
2023 (41015)
2022 (52277)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33023)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (747)
Alabama (78)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (40162)
Australia (6677)
California (9580)
Canada (2882)
China (897)
Colorado (400)
Connecticut (420)
Delaware (269)
Europe (88042)
Florida (1411)
Georgia (308)
Hawaii (2)
Idaho (60)
Illinois (742)
India (48)
Indiana (456)
Iowa (20)
Japan (329)
Kansas (123)
Kentucky (36)
Louisiana (19)
Maine (68)
Maryland (1249)
Massachusetts (7103)
Michigan (285)
Minnesota (554)
Mississippi (4)
Missouri (112)
Montana (31)
Nebraska (25)
Nevada (103)
New Hampshire (77)
New Jersey (2640)
New Mexico (30)
New York (2573)
North Carolina (1337)
North Dakota (9)
Northern California (4452)
Ohio (289)
Oklahoma (20)
Oregon (41)
Pennsylvania (1995)
Puerto Rico (19)
Rhode Island (44)
South America (1113)
South Carolina (49)
South Dakota (1)
Southern California (3673)
Tennessee (149)
Texas (1473)
United States (34791)
Utah (285)
Virginia (229)
Washington D.C. (78)
Washington State (805)
West Virginia (4)
Wisconsin (84)
Wyoming (2)
730,015 Results for "jecure therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics
October 30, 2025
·
2 min read
Press Releases
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
October 20, 2025
·
5 min read
Press Releases
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
October 9, 2025
·
5 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) at Forefront of Effort to Optimize Next-Generation Cancer Therapies
October 31, 2025
·
3 min read
Press Releases
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
October 9, 2025
·
5 min read
Press Releases
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
October 15, 2025
·
9 min read
Press Releases
AuraVax Therapeutics Inc. receives grant for viral challenge study of new broad acting host-directed therapeutic
September 16, 2025
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
October 8, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference
October 27, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 73,002
Next
